Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A pilot study to improve adherence among MS patients who discontinue treatment against medical advice.
Use of health services in people with multiple sclerosis with and without depressive symptoms: a two-year prospective study.
Identification of Vulnerable Cell Types in Major Brain Disorders Using Single Cell Transcriptomes and Expression Weighted Cell Type Enrichment.
Naturally presented peptides on major histocompatibility complex I and II molecules eluted from central nervous system of multiple sclerosis patients.
Decreased NAA in Gray Matter is Correlated with Decreased Availability of Acetate in White Matter in Postmortem Multiple Sclerosis Cortex.
Cost Offset Analysis of Interferon Beta Disease Modifying Therapies In Relapsing-Remitting Multiple Sclerosis.
Mouse Hepatitis Virus infection remodels Connexin43 mediated gap junction intercellular communication both in vitro and in vivo.
P2X7 Receptor as a Therapeutic Target.
TNFRSF1A in multiple sclerosis: A tale of soluble receptors and signaling cascades.
[Encephalopathy and neuromyelitis optica: the importance of recognising atypical symptoms].
Identification of genetic determinants of the sexual dimorphism in CNS autoimmunity.
[Do new oral therapies show advantages in the basal therapy of multiple sclerosis? Con.]
Structural correlates for fatigue in early relapsing remitting multiple sclerosis.
Friends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative Diseases.
DEMYELINATION/REMYELINATION AND EXPRESSION OF INTERLEUKIN-1β, SUBSTANCE P, NERVE GROWTH FACTOR, AND GLIAL-DERIVED NEUROTROPHIC FACTOR DURING TRIGEMINAL NEUROPATHIC PAIN IN RATS.
Hypothesis: Fingolimod explores new horizons in treatment of lymphoma.
Reliability and validity of the function in sitting test in nonambulatory individuals with multiple sclerosis.
Distinct T cell signatures define subsets of patients with multiple sclerosis.
New pharmacological approaches against chronic bowel and bladder problems in paralytics.
Postural control, falls and fear of falling in people with multiple sclerosis without mobility aids.
Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome.
Hilbert-Huang transform based instrumental assessment of intention tremor in multiple sclerosis.
Purified Cannabidiol, the main non-psychotropic component of Cannabis sativa, alone, counteracts neuronal apoptosis in experimental multiple sclerosis.
Disability profile of multiple sclerosis in New Zealand.
Type I/II Interferon Balance in the Regulation of Brain Physiology and Pathology.
Pages
« first
‹ previous
…
712
713
714
715
716
717
718
719
720
…
next ›
last »